Nemaura Medical (NMRD) Competitors $0.0001 0.00 (0.00%) As of 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock NMRD vs. VRAYQ, AHPI, VIVE, UTRS, MOTS, DRTSW, ANZUW, IONM, ATAKW, and BBLGWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Viveve Medical (VIVE), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), and Bone Biologics (BBLGW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. ViewRay Allied Healthcare Products Viveve Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Nemaura Medical (NASDAQ:NMRD) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, profitability, valuation, risk, earnings, media sentiment and dividends. Does the media refer more to NMRD or VRAYQ? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral ViewRay Neutral Which has more risk and volatility, NMRD or VRAYQ? Nemaura Medical has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, ViewRay has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Do institutionals & insiders believe in NMRD or VRAYQ? 4.4% of Nemaura Medical shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by insiders. Comparatively, 2.5% of ViewRay shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is NMRD or VRAYQ more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A ViewRay N/A N/A N/A Which has better valuation and earnings, NMRD or VRAYQ? Nemaura Medical has higher earnings, but lower revenue than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K1.34-$14.14M-$0.390.00ViewRay$102.21M0.00-$107.33MN/AN/A Does the MarketBeat Community believe in NMRD or VRAYQ? Nemaura Medical received 4 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformNemaura MedicalOutperform Votes457.14% Underperform Votes342.86% ViewRayN/AN/A SummaryNemaura Medical and ViewRay tied by winning 3 of the 6 factors compared between the two stocks. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4,000.00$4.39B$5.56B$8.04BDividend YieldN/A39.93%5.09%4.22%P/E Ratio0.0029.8622.6818.83Price / Sales1.3457.90404.28106.72Price / CashN/A51.0838.1834.62Price / Book0.006.226.794.33Net Income-$14.14M$68.15M$3.22B$247.97M7 Day PerformanceN/A1.00%2.44%2.71%1 Month PerformanceN/A-1.80%3.78%3.37%1 Year PerformanceN/A21.29%17.05%5.80% Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura MedicalN/A$0.00flatN/AN/A$4,000.00$3,017.000.0040VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastGap UpVIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/AN/AN/AN/A$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.22+3.9%N/A-9.6%$0.00N/A0.0080ANZUWAnzu Special Acquisition Corp IN/A$0.03+16.4%N/A-72.6%$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130ATAKWAurora Technology AcquisitionN/A$0.02+26.9%N/AN/A$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$16.90-16.3%N/AN/A$0.00N/A0.002 Related Companies and Tools Related Companies VRAYQ Competitors AHPI Competitors VIVE Competitors UTRS Competitors MOTS Competitors DRTSW Competitors ANZUW Competitors IONM Competitors ATAKW Competitors BBLGW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NMRD Stock Free NMRD Stock Alerts